Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Fitzgerald

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cardiovascular Drugs and Therapy|June 1, 1993
Do partial agonist beta-blockers have improved clinical utility?J D Fitzgerald
Postgraduate Medical Journal|January 1, 1971
Experimental approaches to the prophylaxis and treatment of ischaemic heart diseaseJ D Fitzgerald
Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1970
A new test of the degree of adrenergic beta receptor blockadeJ D Fitzgerald
Proceedings of the Royal Society of Medicine|September 1, 1972
Cardioselective beta-adrenergic blockadeJ D Fitzgerald
European Heart Journal|September 1, 1987
By what means might beta blockers prolong life after acute myocardial infarction?J D Fitzgerald
Postgraduate Medical Journal|December 1, 1976
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular diseaseJ D Fitzgerald
Cardiovascular Drugs and Therapy|June 1, 1991
The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomesJ D Fitzgerald
Expert Opinion on Investigational Drugs|July 5, 2005
SMI meeting: innovations in cardiovascular drugs. March 3-4, 1999, London, UKJ D Fitzgerald
Cardiology|January 1, 1971
The effects of -blocking drugs on atrioventricular conduction and contractilityJ D Fitzgerald, J Wale
Experimental & Applied Acarology|March 3, 2001
Differences in biological characteristics in organophosphorus-resistant strains of the phytoseiid mite Typhlodromus pyriJ D Fitzgerald, M G Solomon
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cardiovascular Drugs and Therapy|June 1, 1993
Do partial agonist beta-blockers have improved clinical utility?J D Fitzgerald
Postgraduate Medical Journal|January 1, 1971
Experimental approaches to the prophylaxis and treatment of ischaemic heart diseaseJ D Fitzgerald
Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1970
A new test of the degree of adrenergic beta receptor blockadeJ D Fitzgerald
Proceedings of the Royal Society of Medicine|September 1, 1972
Cardioselective beta-adrenergic blockadeJ D Fitzgerald
European Heart Journal|September 1, 1987
By what means might beta blockers prolong life after acute myocardial infarction?J D Fitzgerald
Postgraduate Medical Journal|December 1, 1976
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular diseaseJ D Fitzgerald
Cardiovascular Drugs and Therapy|June 1, 1991
The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomesJ D Fitzgerald
Expert Opinion on Investigational Drugs|July 5, 2005
SMI meeting: innovations in cardiovascular drugs. March 3-4, 1999, London, UKJ D Fitzgerald
Cardiology|January 1, 1971
The effects of -blocking drugs on atrioventricular conduction and contractilityJ D Fitzgerald, J Wale
Experimental & Applied Acarology|March 3, 2001
Differences in biological characteristics in organophosphorus-resistant strains of the phytoseiid mite Typhlodromus pyriJ D Fitzgerald, M G Solomon
Pageof 5